• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 - 2021年亚太地区预期寿命和健康调整预期寿命的趋势与分布

Trends and Distribution of Life Expectancy and Health-Adjusted Life Expectancy - Asia-Pacific Region, 1990-2021.

作者信息

Luo Yanan, Zhong Panliang, Huang Yujie, Zhao Yihao, Hong Chenlu, Zheng Xiaoying

机构信息

Department of Global Health, School of Public Health, Peking University, Beijing, China.

Institute for Global Health and Development, Peking University, Beijing, China.

出版信息

China CDC Wkly. 2024 Sep 27;6(39):996-1003. doi: 10.46234/ccdcw2024.208.

DOI:10.46234/ccdcw2024.208
PMID:39502896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11532511/
Abstract

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: The Asia-Pacific region is the most populous and diverse globally, encompassing nations with both the longest and shortest life expectancies (LE). However, less is known about the health-adjusted life expectancy (HALE) situation in this region.

WHAT IS ADDED BY THIS REPORT?: This study found diversity in the levels and trends of HALE among countries in the Asia-Pacific region, with HALE in 2021 ranging from 49.87 years in Afghanistan to 74.96 years in Singapore. The largest HALE increase from 1990 to 2021 was observed in the Lao People's Democratic Republic and the smallest in Fiji. HALE continually increased as SDI increased, but different patterns of HALE across countries varied by SDI level.

WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: The diversity among these countries provides a prerequisite and scientific basis for promoting the achievement of health goals in the Asia-Pacific region through multilateral and bilateral cooperation.

摘要

关于该主题已知的信息有哪些?:亚太地区是全球人口最多且最多样化的地区,涵盖了预期寿命最长和最短的国家。然而,关于该地区健康调整生命 expectancy(HALE)的情况却知之甚少。

本报告补充了哪些内容?:本研究发现亚太地区各国之间HALE的水平和趋势存在差异,2021年HALE从阿富汗的49.87岁到新加坡的74.96岁不等。1990年至2021年期间,老挝人民民主共和国的HALE增幅最大,斐济最小。随着社会人口指数(SDI)的增加,HALE持续上升,但各国不同的HALE模式因SDI水平而异。

对公共卫生实践有哪些启示?:这些国家之间的差异为通过多边和双边合作促进亚太地区实现健康目标提供了前提条件和科学依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/11532511/6c7da9436c66/ccdcw-6-39-996-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/11532511/153008c4f265/ccdcw-6-39-996-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/11532511/6c7da9436c66/ccdcw-6-39-996-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/11532511/153008c4f265/ccdcw-6-39-996-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/11532511/6c7da9436c66/ccdcw-6-39-996-2.jpg

相似文献

1
Trends and Distribution of Life Expectancy and Health-Adjusted Life Expectancy - Asia-Pacific Region, 1990-2021.1990 - 2021年亚太地区预期寿命和健康调整预期寿命的趋势与分布
China CDC Wkly. 2024 Sep 27;6(39):996-1003. doi: 10.46234/ccdcw2024.208.
2
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、地区和国家残疾调整生命年(DALYs)359 种疾病和伤害以及 195 个国家和地区 1990-2017 年的健康期望寿命(HALE):2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3.
3
Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE) in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015.1990 - 2015年伊朗及其邻国315种疾病和损伤的伤残调整生命年(DALYs)及健康预期寿命(HALE):全球疾病负担研究2015的结果
Arch Iran Med. 2017 Jul;20(7):403-418.
4
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家残疾调整生命年(DALYs)用于 333 种疾病和伤害以及 195 个国家和地区的健康期望寿命(HALE),1990-2016 年:全球疾病负担研究 2016 年的系统分析。
Lancet. 2017 Sep 16;390(10100):1260-1344. doi: 10.1016/S0140-6736(17)32130-X.
5
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家315种疾病和损伤的伤残调整生命年(DALYs)及健康预期寿命(HALE):全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1603-1658. doi: 10.1016/S0140-6736(16)31460-X.
6
Divergences and gaps in life expectancy and health-adjusted life expectancy in Mexico: Contribution analysis of the Global Burden of Disease Study 2019.墨西哥在预期寿命和健康调整预期寿命方面的差异和差距:2019 年全球疾病负担研究的贡献分析。
PLoS One. 2023 Nov 6;18(11):e0293881. doi: 10.1371/journal.pone.0293881. eCollection 2023.
7
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
8
Life expectancy and healthy life expectancy of Japan: the fastest graying society in the world.日本的预期寿命和健康预期寿命:世界上老龄化速度最快的社会。
BMC Res Notes. 2016 Oct 28;9(1):482. doi: 10.1186/s13104-016-2281-2.
9
A comparative, correlate analysis and projection of global and regional life expectancy, healthy life expectancy, and their GAP: 1995-2025.全球和区域预期寿命、健康预期寿命及其差距的比较、关联分析和预测:1995-2025 年。
J Glob Health. 2020 Dec;10(2):020407. doi: 10.7189/jogh.10.020407.
10
Health-Adjusted Life Expectancy (HALE) in Korea: 2005-2011.韩国的健康调整生命预期(HALE):2005 - 2011年
J Korean Med Sci. 2016 Nov;31 Suppl 2(Suppl 2):S139-S145. doi: 10.3346/jkms.2016.31.S2.S139.

本文引用的文献

1
Trends in the burden and determinants of HIV in the Asia-Pacific region (1990-2019): An age-period-cohort analysis of the 2019 Global Burden of Disease Study.亚太地区艾滋病毒负担和决定因素的趋势(1990-2019 年):2019 年全球疾病负担研究的年龄-时期-队列分析。
J Med Virol. 2024 Jun;96(6):e29724. doi: 10.1002/jmv.29724.
2
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
3
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区及 811 个次国家级行政单位 1950 年至 2021 年的全球年龄、性别特异性死亡率、预期寿命和人口估计,以及 COVID-19 大流行的影响:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):1989-2056. doi: 10.1016/S0140-6736(24)00476-8. Epub 2024 Mar 11.
4
Estimating indirect mortality impacts of armed conflict in civilian populations: panel regression analyses of 193 countries, 1990-2017.估算武装冲突对平民人口间接死亡的影响:1990-2017 年 193 个国家的面板回归分析。
BMC Med. 2020 Sep 10;18(1):266. doi: 10.1186/s12916-020-01708-5.
5
COVID-19 and China: lessons and the way forward.新冠疫情与中国:经验教训及未来之路
Lancet. 2020 Jul 25;396(10246):213. doi: 10.1016/S0140-6736(20)31637-8.
6
Health, functioning, and disability in older adults--present status and future implications.老年人的健康、功能与残疾——现状及未来影响
Lancet. 2015 Feb 7;385(9967):563-75. doi: 10.1016/S0140-6736(14)61462-8. Epub 2014 Nov 6.
7
Human resources for health in southeast Asia: shortages, distributional challenges, and international trade in health services.东南亚的卫生人力资源:短缺、分布挑战和卫生服务国际贸易。
Lancet. 2011 Feb 26;377(9767):769-81. doi: 10.1016/S0140-6736(10)62035-1. Epub 2011 Jan 25.
8
Permutation tests for joinpoint regression with applications to cancer rates.用于连接点回归的排列检验及其在癌症发病率中的应用。
Stat Med. 2000 Feb 15;19(3):335-51. doi: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z.